All Videos Channels
  1. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    19
  2. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    27
  3. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    20
  4. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    21
  5. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    18
  6. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    21
  7. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    26
  8. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  9. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  10. Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    20
  11. Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    12
  12. Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    16
  13. Novo Nordisk's New Obesity Drug: Game Changer? #shorts

    Novo Nordisk's New Obesity Drug: Game Changer? #shorts

    12
  14. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    25
  15. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    22
  16. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  17. Novo Nordisk's New Weight Drug Disappoints | World Business Watch

    Novo Nordisk's New Weight Drug Disappoints | World Business Watch

    25
  18. Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging

    Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging

    13